Metabolic response patterns of nucleotides in B-cell chronic lymphocytic leukaemias to cladribine, fludarabine and deoxycoformycin

Leukemia Research

Volumn 28, Issue 7, 2004, Pages 725-731

  Wilson, Paul K ^a   Mulligan, Stephen P ^a,b   Christopherson, Richard I ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Department of Geriatric Medicine   (Australia)

Author keywords

Cladribine; Deoxycoformycin; Fludarabine; Leukaemia; Metabolomics; Nucleotides

Indexed keywords

ACETIC ACID DERIVATIVE; CLADRIBINE; DEOXYADENOSINE TRIPHOSPHATE; DINUCLEOTIDE; FLUDARABINE; IONOMYCIN; NUCLEOTIDE; PENTOSTATIN; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHATE;

ADULT; AGED; ARTICLE; B CELL LEUKEMIA; CANCER CHEMOTHERAPY; CELL CULTURE; CELL STIMULATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG ACTIVITY; DRUG EXPOSURE; DRUG RESPONSE; HUMAN; HUMAN CELL; MALE; MEASUREMENT; METABOLISM; PRIORITY JOURNAL; TIME;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLADRIBINE; HUMANS; IONOMYCIN; KINETICS; LEUKEMIA, B-CELL, CHRONIC; MALE; MIDDLE AGED; NUCLEOTIDES; PENTOSTATIN; PROGNOSIS; TUMOR CELLS, CULTURED; VIDARABINE;

EID: 2442456742     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2003.11.013     Document Type: Article

References (20)

1. Johnston J.B., Eisenhauer E., Wainman N., Corbett W.E., Zaentz S.D., Daeninck P.J. Long-term outcome following treatment of hairy cell leukemia with pentostatin (Nipent): a National Cancer Institute of Canada study. Semin. Oncol. 27:2000;32-36
2. Rai K.R., Peterson B.L., Appelbaum F.R., Kolitz J., Elias L., Shepherd L., et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia. N. Engl. J. Med. 343:2000;1750-1757
3. Waselenko J.K., Grever M.R., Beer M., Lucas M.A., Byrd J.C. Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia. Semin. Oncol. 27:2000;44-51
4. Robak T. Cladribine in the treatment of chronic lymphocytic leukemia. Leuk Lymphoma. 40:2001;551-564
5. Carson D.A., Wasson D.B., Kaye J., Ullman B., Martin D.W. Jr., Robins R.K., et al. Deoxycytidine kinase-mediated toxicity of deoxyadenosine analogs toward malignant human lymphoblasts in vitro and toward murine L1210 leukemia in vivo. Proc. Natl. Acad. Sci. USA. 77:1980;6865-6869
6. Dow L.W., Bell D.E., Poulakos L., Fridland A. Differences in metabolism and cytotoxicity between 9-beta-D-arabinofuranosyladenine and 9-beta-D-arabinofuranosyl-2-fluoroadenine in human leukemic lymphoblasts. Cancer Res. 40:1980;1405-1410
7. Siaw M.F., Coleman M.S. In vitro metabolism of deoxycoformycin in human T lymphoblastoid cells. Phosphorylation of deoxycoformycin and incorporation into cellular DNA. J. Biol. Chem. 259:1984;9426-9433
8. Parker W.B., Bapat A.R., Shen J.X., Townsend A.J., Cheng Y.C. Interaction of 2-halogenated dATP analogs (F, Cl, and Br) with human DNA polymerases, DNA primase, and ribonucleotide reductase. Mol. Pharmacol. 34:1988;485-491
9. Huang P., Plunkett W. Action of 9-β-D-arabinosyl-2-fluoroadenine on RNA metabolism. Mol. Pharmacol. 39:1991;449-455
10. Catapano C.V., Perrino F.W., Fernandes D.J. Primer RNA chain termination induced by 9-beta-D-arabinofuranosyl-2-fluoroadenine 5′-triphosphate. A mechanism of DNA synthesis inhibition. J. Biol. Chem. 268:1993;7179-7185
11. Huang P., Sandoval A., Van Den Neste E., Keating M.J., Plunkett W. Inhibition of RNA transcription: a biochemical mechanism of action against chronic lymphocytic leukemia cells by fludarabine. Leukemia. 14:2000;1405-1413
12. Li L., Liu X., Glassman A.B., Keating M.J., Stros M., Plunkett W., et al. Fludarabine triphosphate inhibits nucleotide excision repair of cisplatin-induced DNA adducts in vitro. Cancer Res. 57:1997a;1487-1494
13. Leoni L.M., Chao Q., Cottam H.B., Genini D., Rosenbach M., Carrera C.J., et al. Induction of an apoptotic program in cell-free extracts by 2-chloro-2′-deoxyadenosine 5′-triphosphate and cytochrome c. Proc. Natl. Acad. Sci. USA. 95:1998;9567-9571
14. Agarwal R.P., Spector T., Parks R.E.J. Tight-binding inhibitors-IV. Inhibition of adenosine deaminase by various inhibitors. Biochem. Pharmacol. 26:1977;359-367
15. Reichard P., Eliasson R., Ingemarson R., Thelander L. Cross-talk between the allosteric effector-binding sites in mouse ribonucleotide reductase. J. Biol. Chem. 275:2000;33021-33026
16. Li P., Nijhawan D., Budihardjo I., Srinivasula S.M., Ahmad M., Alnemri E.S., et al. Cytochrome c and dATP-dependent formation of Apaf-1/Caspase-9 complex initiates an apoptotic protease cascade. Cell. 91:1997;479-489
17. Wilson P.K., Szabados E., Mulligan S.P., Christopherson R.I. Comparative effects of cladribine, fludarabine and pentostatin on nucleotide metabolism in T- and B-cell lines. Int. J. of Biochem. Cell Biol. 30:1998;833-842
18. Ingemarson R., Thelander L. A kinetic study on the influence of nucleoside triphosphate effectors on subunit interaction in mouse ribonucleotide reductase. Biochem. 35:1996;8603-8609
19. Alizadeh A.A., Eisen M.B., Davis R.E., Ma C., Lossos I.S., Rosenwald A., et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 403:2000;503-511
20. Belov L., de la Vega O., dos Remedios C.G., Mulligan S.P., Christopherson R.I. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray. Cancer Res. 61:2001;4483-4489